Brevilin A attenuates cartilage destruction in osteoarthritis mouse model by inhibiting inflammation and ferroptosis via SIRT1/Nrf2/GPX4 signaling pathway
Who Might Benefit from BPC-157 Treatment
10.1016/S0074-7742(07)82016-2 Int Rev Neurobiol
In some embodiments, the formulations or compositions described herein have a pH and osmolarity as described herein, and have a concentration of active pharmaceutical ingredient between about 1 M and about 10 M, between about 1 mM and about 100 mM, between about 0.1 mM and about 100 mM, between about 0.1 mM and about 100 nM
European Journal of Radiology , 82 (11), e676679
Funding This work was supported by the National Natural Science Foundation of China (81870593, 82170865), Natural Science Foundation of Shandong Province of China (ZR2020MH106) and Clinical research of Affiliated Hospital of Weifang Medical University (2021wyfylcyj05)